Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PHARMACIE MONTEMONT : revenue, balance sheet and financial ratios

PHARMACIE MONTEMONT is a French company founded 2 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in FOUG (54570), this company of category PME shows in 2025 a net income positive of 84 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-18

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Historique financier - PHARMACIE MONTEMONT (SIREN 979125838)
Indicador 2025 2024
Ingresos N/C N/C
Resultado neto 84 264 € 32 456 €
EBITDA N/C N/C
Margen neto N/C N/C

Ingresos y cuenta de resultados

In 2025, PHARMACIE MONTEMONT generates positive net income of 84 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2024-2025: 32 k€ -> 84 k€.

Resultado neto (2025) ?
Resultado neto
Definición
Bénéfice ou perte après toutes les charges, y compris impôts et éléments exceptionnels.
Fórmula
Resultado corriente + Resultado excepcional - Impuesto sobre beneficios

84 264 €

Chargement du compte de résultat...

Évolution graphique

Mostrar :

Activo

Chargement des données...

Pasivo

Chargement des données...

Ratios de solvencia y endeudamiento

The debt ratio (= Financial debt / Equity x 100) stands at 407%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 17%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Ratio de endeudamiento (2025) ?
Ratio de endeudamiento
Definición
Mide la proporción de deuda respecto a los fondos propios.
Fórmula
(Deuda financiera / Fondos propios) x 100
Interpretación
< 50% : Faible
50-100% : Moderado
> 100% : Alto

407.017%

Autonomía financiera (2025) ?
Autonomía financiera
Definición
Porcentaje de fondos propios en la financiación total.
Fórmula
(Fondos propios / Total balance) x 100
Interpretación
> 30% : Buena autonomía
20-30% : Media
< 20% : Faible

16.915%

Ratio de obsolescencia (2025) ?
Ratio de obsolescencia
Definición
Mide el grado de desgaste del inmovilizado material.
Fórmula
Amortización acumulada / Inmovilizado bruto x 100
Interpretación
< 50% : Activos recientes
50-70% : Desgaste normal
> 70% : Activos envejecidos

75.2%

Evolución de indicadores de solvencia
PHARMACIE MONTEMONT

Positionnement sectoriel

Debt ratio
407.02 2025
2024
2025
Q1: 13.57
Méd: 49.47
Q3: 128.28
Average

In 2025, the debt ratio of PHARMACIE MONTEMONT (407.02) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
16.91% 2025
2024
2025
Q1: 33.69%
Méd: 53.88%
Q3: 72.26%
Watch

In 2025, the financial autonomy of PHARMACIE MONTEMONT (16.9%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Ratios de liquidez

The liquidity ratio (= Current assets / Current liabilities) stands at 168.95. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Ratio de liquidez (2025) ?
Ratio de liquidez
Definición
Capacidad para pagar las deudas a corto plazo con el activo circulante.
Fórmula
Activo circulante / Pasivo circulante
Interpretación
> 1.5 : Muy bueno
1-1.5 : Correcto
< 1 : Risque de liquidité

168.948

Evolución de indicadores de liquidez
PHARMACIE MONTEMONT

Positionnement sectoriel

Liquidity ratio
168.95 2025
2024
2025
Q1: 131.48
Méd: 182.6
Q3: 258.72
Average

In 2025, the liquidity ratio of PHARMACIE MONTEMONT (168.95) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Positionnement de PHARMACIE MONTEMONT dans son secteur

Comparación con el sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Estimación de valoración

Based on 277 transactions of similar company sales in 2025, the value of PHARMACIE MONTEMONT is estimated at 1 338 543 € (range 908 342€ - 2 100 359€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
908k€ 1338k€ 2100k€
1 338 543 € Range: 908 342€ - 2 100 359€
NAF 5 année 2025

Valuation method used

Net Income Multiple
84 264 € × 15.9x = 1 338 544 €
Range: 908 342€ - 2 100 359€

Only this financial indicator is available for this company.

Evolución de la valoración

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE MONTEMONT with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE MONTEMONT

What is the revenue of PHARMACIE MONTEMONT ?

The revenue of PHARMACIE MONTEMONT is not publicly disclosed (confidential accounts filed with INPI).

Is PHARMACIE MONTEMONT profitable?

Yes, PHARMACIE MONTEMONT generated a net profit of 84 k€ in 2025.

Where is the headquarters of PHARMACIE MONTEMONT ?

The headquarters of PHARMACIE MONTEMONT is located in FOUG (54570), in the department Meurthe-et-Moselle.

Where to find the tax return of PHARMACIE MONTEMONT ?

The tax return of PHARMACIE MONTEMONT is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE MONTEMONT operate?

PHARMACIE MONTEMONT operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.